BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pachón-Angona I, Maj M, Wnorowski A, Martin H, Jóźwiak K, Ismaili L. Synthesis of new Hantzsch adducts showing Ca2+ channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Med Chem 2021;13:1717-29. [PMID: 34402661 DOI: 10.4155/fmc-2021-0176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Grosjean S, Pachón-Angona I, Dawra M, Refouvelet B, Ismaili L. Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapy. Future Med Chem 2022. [PMID: 36263996 DOI: 10.4155/fmc-2022-0170] [Reference Citation Analysis]
2 Ismaili L, Bernard PJ, Refouvelet B. Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction. Future Med Chem 2022. [PMID: 35608057 DOI: 10.4155/fmc-2022-0080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]